Patent Oppositions in genetic engineering industry

Explore the competitive field of genetic engineering where companies are constantly innovating to stay ahead. Discover the latest patent opposition trends, top companies filing and facing patent oppositions, and the most recent patents under dispute. Stay informed on patent activity in genetic engineering technology and learn how to protect your intellectual property.

Explore the top companies that have filed the most patent oppositions in the technology industry.

Explore the top companies that have faced the most patent oppositions in the technology industry.

Explore the top law firms that have filed the most patent oppositions in the technology industry.

Patent challenges are becoming increasingly common in the genetic engineering industry as companies work to protect their innovations in a highly competitive market. These legal battles can significantly impact the development and release of new technologies. Below is a list of the latest patents that have been opposed in the genetic engineering industry, offering a snapshot of the ongoing struggles over intellectual property rights. For anyone involved in this industry, understanding these patent disputes is essential for navigating its future.

Last updated on: Feb 12, 2026
Patent NumberTitleApplicantOpposition DateOpposition Name
Rna-Guided Human Genome EngineeringPRESIDENT AND FELLOWS OF HARVARD COLLEGEJan 30, 2026SCHLICH
Methods For Targeted Insertion Of Dna In GenesBLUEALLELEJan 2, 2026PATENT BOUTIQUE
Chimeric Antigen Receptors Targeting B-Cell Maturation AntigenTHE UNITED STATES OF AMERICADec 31, 2025BOULT WADE TENNANT
Rna-Guided Human Genome EngineeringPRESIDENT AND FELLOWS OF HARVARD COLLEGEDec 30, 2025VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB
Methods For Targeted Insertion Of Dna In GenesBLUEALLELEDec 29, 2025NOVO NORDISK
Engineering Of Systems, Methods And Optimized Guide Compositions For Sequence ManipulationMASSACHUSETTS INSTITUTE OF TECHNOLOGYDec 19, 2025GRUND GROUP PATENTANWALTE UND SOLICITOR PARTG MBB
Targeted Lipid Particles For Systemic Delivery Of Nucleic Acid Molecules To LeukocytesRAMOT AT TEL AVIV UNIVERSITYDec 18, 2025KARO
Targeted Lipid Particles For Systemic Delivery Of Nucleic Acid Molecules To LeukocytesRAMOT AT TEL AVIV UNIVERSITYDec 15, 2025STRAWMAN
Delivery, Engineering And Optimization Of Systems, Methods And Compositions For Sequence Manipulation And Therapeutic ApplicationsPRESIDENT AND FELLOWS OF HARVARD COLLEGEDec 12, 2025GRUND IPG PATENTANWALTE UND SOLICITOR PARTG MBB
Dna-Pkcs Inhibitors For Increasing Genome Editing EfficiencyMAX PLANCK GESELLSCHAFT ZUR FRDERUNG DER WISSENSCHAFTEN EVDec 4, 2025MAIWALD

To stay ahead in the competitive genetic engineering industry, companies are constantly innovating. Here are the top patents facing oppositions in the genetic engineering industry. Stay informed on the latest opposition trends and learn how to protect your intellectual property.

Last updated on: Feb 12, 2026
Patent NumberPublication DateTitleApplicantTotal Oppositions
Sep 19, 2018Methods Of Cell CultureMOMENTA PHARMACEUTICALS10
Mar 2, 2022Modified Nucleoside, Nucleotide, And Nucleic Acid CompositionsMODERNA10
Sep 20, 2017Crispr-Based Genome Modification And RegulationSIGMA ALDRICH10
Dec 5, 2018Crispr-Based Genome Modification And RegulationSIGMA ALDRICH9
May 18, 2022Ribonucleic Acids Containing N1-Methyl-Pseudouracils And Uses ThereofMODERNA9
Oct 9, 2019Crispr-Based Genome Modification And RegulationSIGMA ALDRICH8
Oct 2, 2019Crispr-Based Genome Modification And RegulationSIGMA ALDRICH8
Jan 10, 2018Scalable Lentiviral Vector Production System Compatible With Industrial Pharmaceutical ApplicationsGENETHON8
Aug 7, 2019Methods To Mobilize Progenitor/Stem CellsGENZYME7
Apr 19, 2017Oligopeptide-Free Cell Culture MediaBAXTER HEALTHCARE7